I received the following email from Bridget Kimmel, Senior Manager of Communications & Public Affairs for Johnson & Johnson Diabetes Care Companies Animas Corporation & Life Scan, Inc. I know people have been speaking about this device and I share with you what was sent to me without edit.
I’m pleased to share that FDA has approved the use of the Animas® Vibe® Insulin Pump and Continuous Glucose Monitoring (CGM) System for the management of diabetes in children and adolescents, ages 2 to 17.
The Animas® Vibe® System was the first integrated system with Dexcom G4® PLATINUM CGM technology and is the only such system available in the U.S. for pediatric patients as young as age 2.
As an integrated system, the Animas® Vibe® System allows patients and their caregivers to view glucose data and administer insulin right from the pump, making it easy to fine tune insulin delivery to help manage their diabetes. We know that effective glucose management early in life supports better health outcomes in adulthood; therefore, the Animas® Vibe® System is a great step forward in helping children and their caregivers in the U.S. take ownership of their diabetes.
Expanding the global presence of the Animas® Vibe® System, along with providing solutions for children with diabetes and their parents, has been a top priority for Johnson & Johnson Diabetes Care Companies (JJDCC). It’s been our goal as a company to not only develop the best treatment solutions available, but also ensure that every member of the diabetes community, including children, may access these tools.
For more details on the FDA approval, please view the press release we issued today here.
Orders for the Animas® Vibe® System are currently being accepted, with anticipated shipment to patients beginning this month. In the meantime, if you have any questions, please don’t hesitate to e-mail me or give me a call at 215-688-6033.
I am a DiabetesDad.
Please visit my Diabetes Dad FB Page and hit ‘like’.